Paxillin confers resistance to tyrosine kinase inhibitors in EGFR-mutant lung cancers via modulating BIM and Mcl-1 protein stability
Crossref DOI link: https://doi.org/10.1038/onc.2015.120
Published Online: 2015-04-27
Published Print: 2016-02-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, D-W
Chen, C-Y
Chu, C-L
Lee, H
Text and Data Mining valid from 2015-04-27
Version of Record valid from 2015-04-27
Article History
Received: 15 September 2014
Revised: 11 March 2015
Accepted: 13 March 2015
First Online: 27 April 2015
Competing interests
: The authors declare no conflict of interest.